Access
To read this story in full you will need to login or make a payment (see right).
Outlook
Nature 449, 158-159 (13 September 2007) | doi:10.1038/449158a; Published online 12 September 2007
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Assistant Professor of Medicine
- Massachusetts General Hospital
- Boston, MA
Chemical Process Engineer
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Neglected Diseases Lost in translation
Declan Butler1
Abstract
The culture of academia needs to change if scientists are to bridge the gap between research and the development of drugs and vaccines for neglected diseases in the developing world, says Declan Butler.
Read any scientific paper or grant proposal on basic research into neglected diseases and you inevitably find a claim that the work could lead to new therapies for diseases that affect millions of people in the developing world. Few, in fact, ever do, and scientists, universities and research funders are waking up to the fact that part of the blame lies with them and their perpetuation of a reward culture that focuses excessively on papers and patents, and not on whether the research actually benefits society.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
